GABAPENTIN NYCOMED 300 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

gabapentin nycomed 300 mg kapseli, kova

nycomed danmark aps - gabapentinum - kapseli, kova - 300 mg - gabapentiini

GABAPENTIN NYCOMED 400 mg kapseli, kova Suomi - suomi - Fimea (Suomen lääkevirasto)

gabapentin nycomed 400 mg kapseli, kova

nycomed danmark aps - gabapentinum - kapseli, kova - 400 mg - gabapentiini

Zolsketil pegylated liposomal Euroopan unioni - suomi - EMA (European Medicines Agency)

zolsketil pegylated liposomal

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Somac Control Euroopan unioni - suomi - EMA (European Medicines Agency)

somac control

takeda gmbh - pantopratsoli - gastroesofageaalinen refluksi - protonipumpun estäjät - refluksi-oireiden lyhytkestoinen hoito (esim. närästys, hapon regurgitaatio) aikuisilla.

Coversyl Comp Novum 5 mg / 1,25 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

coversyl comp novum 5 mg / 1,25 mg tabletti, kalvopäällysteinen

les laboratoires servier - indapamide, perindopril arginine - tabletti, kalvopäällysteinen - 5 mg / 1,25 mg - perindopriili ja diureetit

Coversyl Comp Novum 10 mg / 2,5 mg tabletti, kalvopäällysteinen Suomi - suomi - Fimea (Suomen lääkevirasto)

coversyl comp novum 10 mg / 2,5 mg tabletti, kalvopäällysteinen

les laboratoires servier - indapamide, perindopril arginine - tabletti, kalvopäällysteinen - 10 mg / 2,5 mg - perindopriili ja diureetit

Vyxeos liposomal (previously known as Vyxeos) Euroopan unioni - suomi - EMA (European Medicines Agency)

vyxeos liposomal (previously known as vyxeos)

jazz pharmaceuticals ireland limited - daunorubicin hydrochloride, cytarabine - leukemia, myeloidi, akuutti - antineoplastiset aineet - vyxeos liposomaalista on tarkoitettu hoitoon aikuisilla, joilla on äskettäin diagnosoitu, hoito-liittyvän akuutin myelooisen leukemian (t-aml) tai aml myelodysplasia liittyviä muutoksia (aml-mrc).

Myocet liposomal (previously Myocet) Euroopan unioni - suomi - EMA (European Medicines Agency)

myocet liposomal (previously myocet)

teva b.v. - doksorubisiinihydrokloridia - rintojen kasvaimet - antineoplastiset aineet - myocet liposomaalista, yhdessä syklofosfamidin kanssa on tarkoitettu ensilinjan hoito metastasoituneen rintasyövän hoidossa aikuisilla naisilla.

Somac 40 mg enterotabletti Suomi - suomi - Fimea (Suomen lääkevirasto)

somac 40 mg enterotabletti

takeda gmbh - pantoprazole sodium sesquihydrate - enterotabletti - 40 mg - pantopratsoli